VIRAX BIOLABS GROUP LTD
VRAX · NASDAQ
Updated at 2026-10-14 09:34:49
- Today's High
- $1.86
- Today’s Low
- $1.72
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $1.81
- Previous Close
- $1.85
- Volume
- 71.26K
- Market Cap
- $2.48M
- P/E Ratio
- --
- EPS
- $-23.08
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Health Care
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- BIOCITY GLASGOW, LANARKSHIRE, UNITED KINGDOM, ML1 5UH
- Country
- GB
- Listing Date
- 2022-07-14
- Fiscal Year End
- March
- Shares Outstanding
- 800K
- CIK
- 0001885827
- Website
- www.viraxbiolabs.com
Virax Biolabs Group Limited, a biotechnology company, sells, distributes and markets diagnostic test kits and medical technology products and PPE for the prevention, detection, diagnosis and risk management of viral diseases in the field of immunology. The company is headquartered in London, the United Kingdom.
Financial Metrics
Revenue
2026-06-30
$12.42K
2025-09-30
$1.6K
2025-06-30
$1.37K
2024-09-30
$4.95K
Operating Expenses
2026-06-30
$6.4M
2025-09-30
$2.37M
2025-06-30
$3.23M
2024-09-30
$2.87M
Net Income
2026-06-30
-$5.02M
2025-09-30
-$2.33M
2025-06-30
-$3.3M
2024-09-30
-$2.75M
Net Profit Margin
2026-06-30
-40.43K%
2025-09-30
-145.44K%
2025-06-30
-239.82K%
2024-09-30
-55.65K%
Earnings Per Share
2026-06-30
--
2025-09-30
$-0.49
2025-06-30
$-0.76
2024-09-30
$-0.89
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$5.64M
2025-09-30
-$2.36M
2025-06-30
-$3.09M
2024-09-30
-$2.72M
Effective Tax Rate
2026-06-30
15.17%
2025-09-30
10.45%
2025-06-30
--
2024-09-30
4.72%
| Item | 2026-06-30 | 2025-09-30 | 2025-06-30 | 2024-09-30 |
|---|---|---|---|---|
| Revenue | $12.42K | $1.6K | $1.37K | $4.95K |
| Operating Expenses | $6.4M | $2.37M | $3.23M | $2.87M |
| Net Income | -$5.02M | -$2.33M | -$3.3M | -$2.75M |
| Net Profit Margin | -40.43K% | -145.44K% | -239.82K% | -55.65K% |
| Earnings Per Share | -- | $-0.49 | $-0.76 | $-0.89 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$5.64M | -$2.36M | -$3.09M | -$2.72M |
| Effective Tax Rate | 15.17% | 10.45% | -- | 4.72% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.